Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study

Translational Gastroenterology and Hepatology ◽

10.21037/tgh.2018.09.11 ◽

2018 ◽

Vol 3 ◽

pp. 72-72 ◽

Cited By ~ 6

Author(s):

Ovidiu Burta ◽

Claudia Iacobescu ◽

Radu Bogdan Mateescu ◽

Tudor Nicolaie ◽

Nicoleta Tiuca ◽

...

Keyword(s):

Clinical Study ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group ◽

Functional Bloating

Download Full-text

A DOUBLE BLIND, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, CLINICAL STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF LOW DOSE DOXEPIN IN COMPARISION WITH ZOPICLONE IN ADULT AND ELDERLY PATIENTS WITH PRIMARY INSOMNIA

Journal of Evolution of Medical and Dental Sciences ◽

10.14260/jemds/2015/2241 ◽

2015 ◽

Vol 4 (91) ◽

pp. 15603-15608

Author(s):

Pali Rastogi ◽

Deepti Rastogi

Keyword(s):

Clinical Study ◽

Elderly Patients ◽

Low Dose ◽

Primary Insomnia ◽

Prospective Clinical Study ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

Download Full-text

Efficacy and safety of Onkyeong-tang in treating cold hypersensitivity in the feet of Korean women: protocol for a double-blind, randomized, placebo-controlled, parallel-group, multicenter clinical study

Trials ◽

10.1186/s13063-020-04265-7 ◽

2020 ◽

Vol 21 (1) ◽

Author(s):

Kyou-Young Lee ◽

In-Sik Han ◽

Ho-Yeon Go ◽

Dong-Nyung Lee ◽

Jun-Sang Yu ◽

...

Keyword(s):

Clinical Study ◽

Korean Women ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group ◽

Cold Hypersensitivity ◽

Multicenter Clinical Study

Download Full-text

Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.01.009 ◽

2016 ◽

Vol 38 (3) ◽

pp. 557-573 ◽

Cited By ~ 1

Author(s):

Han Cheol Lee ◽

Sang-Rok Lee ◽

Kyoo-Rok Han ◽

Cheol-Woong Yu ◽

Chang-Gyu Park ◽

...

Keyword(s):

Clinical Study ◽

Occlusive Disease ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

Download Full-text

A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in Subjects with Functional Dyspepsia

Journal of Dietary Supplements ◽

10.1080/19390211.2020.1856996 ◽

2020 ◽

pp. 1-13

Author(s):

Sanjib Kumar Panda, MPharm ◽

Somashekara Nirvanashetty, PhD ◽

Vivek A. Parachur, BTech ◽

Chakravarthy Krishnamoorthy, MPharm ◽

Shemanti Dey, MSc

Keyword(s):

Clinical Study ◽

Functional Dyspepsia ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Comparative Clinical Study

Download Full-text

Efficacy and safety of generic glatiramer acetate Timexon®: results of the 12-month extension of BCD-063-1 international double-blind randomized placebo-controlled clinical study of efficacy and safety of Timexon® in comparison with Copaxone®

10.26226/morressier.59a3eda8d462b8028d895358 ◽

2017 ◽

Author(s):

Camila Tursunova

Keyword(s):

Clinical Study ◽

Glatiramer Acetate ◽

Efficacy And Safety ◽

Double Blind ◽

Controlled Clinical Study

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793482011 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793480560 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text